You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MRNA Award Disclosure
Andres Juan · SEC Form 4 · Filed Nov 9, 2026
Award
Calculated transaction value
$0
Andres Juan Chief Operating Officer
MRNA
Moderna
MRNA
Transaction date
Nov 5, 2026
Public filing date
Nov 9, 2026
Filing lag
Filed 4 days later
MRNA daily price context
Close on/before transaction
$241.46
Nov 5, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 7,898 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001682852-26-000199
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Moderna, Inc. MRNA | Award | Nov 5, 2026 | $0 |
| Moderna, Inc. MRNA Current | Award | Nov 5, 2026 | $0 |